Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1987-01-02
1990-11-06
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 17, 514 18, 514263, 530329, 530331, 530332, 536 26, 536 27, 544273, A61K 3152
Patent
active
049686720
ABSTRACT:
A functionalized congener approach to drugs acting at A.sub.1 and A.sub.2 adenosine receptor types is applicable to prodrug design. The prodrugs affect a more efficient delivery of the drug at the particular site of the body affected and take advantage of selective biochemical cleavages and alteration in distribution characteristics. In particular, kidney functions and lipid functions are stressed in the invention.
REFERENCES:
patent: 4696932 (1987-09-01), Jacobson et al.
Jacobson et al., The Chemical Abstracts, 107: 59455h (1987).
Daly John W.
Jacobson Kenneth A.
Kirk Kenneth L.
Griffin Ronald W.
The United States of America as represented by the Department of
Wilson James O.
LandOfFree
Adenosine receptor prodrugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenosine receptor prodrugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine receptor prodrugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1306956